Viking Therapeutics grants 190,000 stock options
Viking Therapeutics reported that Chief Medical Officer Hubert C. Chen received a grant of stock options.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Form Type
4
Rhea-AI Filing Summary
Viking Therapeutics reported that Chief Medical Officer Hubert C. Chen received a grant of stock options. The award covers 190,000 options to buy common stock at an exercise price of $31.27 per share, expiring on June 1, 2036. According to the vesting terms, 25% of the options vested immediately on the grant date, with an additional 25% vesting on each one-year anniversary over the next three years. Following this compensation-related grant, Chen holds 190,000 stock options directly.
Insider Trade Summary
Grant/Award: 190,000 shares
Grant/Award
1 txn
Insider
Chen Hubert C
Role
Chief Medical Officer
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Stock Option (Right to Buy) | 190,000 | $0.00 | $0.00 |
Holdings After Transaction:
Stock Option (Right to Buy) — 190,000 contracts (Direct)
Footnotes (1)
- F1. 25% of the shares subject to the option vested immediately, and 25% of the shares subject to the option will vest on each one-year anniversary of the grant date over the next three years.
Key Figures
Stock options granted: 190,000 options
Exercise price: $31.27 per share
Expiration date: June 1, 2036
+3 more
6 metrics
Stock options granted
190,000 options
Grant to Chief Medical Officer on June 1, 2026
Exercise price
$31.27 per share
Strike price for granted stock options
Expiration date
June 1, 2036
Option expiration for the 190,000 options
Immediate vesting portion
25% of options
Vested on the grant date per vesting schedule
Annual vesting installments
25% per year
Each one-year anniversary over the next three years
Options held after grant
190,000 options
Total stock options directly held post-transaction
Key Terms
Stock Option (Right to Buy), exercise price, expiration date, underlying security, +2 more
6 terms
Stock Option (Right to Buy) financial
"security_title: Stock Option (Right to Buy)"
exercise price financial
"conversion_or_exercise_price: 31.2700"
The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.
expiration date financial
"expiration_date: 2036-06-01T00:00:00.000Z"
The expiration date is the deadline after which a financial contract, such as an option or a futures agreement, is no longer valid or can be exercised. It matters to investors because it determines the timeframe during which they can take action or benefit from the contract, similar to how a coupon or a food item has a limited period of usefulness. Once the expiration date passes, the contract loses its value or ability to be used.
underlying security financial
"underlying_security_title: Common Stock"
vesting financial
"shares subject to the option vested immediately, and 25% ... will vest"
Vesting is the process by which you earn full ownership of something, like company stock or a retirement benefit, over time. It’s like earning the right to keep a gift piece by piece the longer you stay with a company, making sure employees stay committed before they receive all the benefits.
Grant, award, or other acquisition financial
"transaction_code_description: Grant, award, or other acquisition"
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transaction did Viking Therapeutics (VKTX) report for Hubert C. Chen?
Viking Therapeutics reported a compensation-related grant of 190,000 stock options to Chief Medical Officer Hubert C. Chen. These options give the right to buy common shares at a fixed exercise price and are disclosed as an acquisition on a Form 4.
What are the key terms of Hubert C. Chen’s 190,000 Viking Therapeutics (VKTX) stock options?
The grant covers 190,000 stock options with an exercise price of $31.27 per share and an expiration date of June 1, 2036. The options are tied to Viking Therapeutics’ common stock as the underlying security.
How do Hubert C. Chen’s Viking Therapeutics (VKTX) options vest?
The vesting schedule provides that 25% of the options vested immediately on the grant date. The remaining 75% will vest in three equal 25% installments on each one-year anniversary of the grant date over the next three years.
Is Hubert C. Chen’s Form 4 transaction in VKTX an open-market purchase or a grant?
The Form 4 shows a grant or award acquisition of derivative securities, not an open-market purchase. The transaction code is “A,” indicating a grant of stock options as compensation rather than buying existing shares in the market.
How many Viking Therapeutics (VKTX) options does Hubert C. Chen hold after this grant?
After the reported transaction, Hubert C. Chen holds 190,000 stock options directly. This total reflects the full amount of the newly granted options as shown in the post-transaction holdings field on the Form 4.
AI-generated analysis. How Rhea-AI works. Not financial advice.
Accepted by SEC EDGAR
Learn about SEC filing dates